Loading publications…
The last 5 uploaded publications
β-Catenin Activation Promotes Immune Escape and Resistance to Anti–PD-1 Therapy in Hepatocellular Carcinoma
Marina Ruiz de Galarreta, Erin Bresnahan, Pedro Molina-Sánchez, Katherine E. Lindblad, Bárbara Maier, Daniela Sia, Marc Puigvehí, Verónica Miguela, María Casanova-Acebes, Maxime Dhainaut, Carlos Villacorta-Martín, Aatur D. Singhi, Akshata Moghe, Johann von Felden, Lauren Tal Grinspan, Shuang Wang, Alice O. Kamphorst, Satdarshan P. Monga, Brian D. Brown, Augusto Villanueva, Josep M. Llovet, Miriam Mérad, Amaia Lujambio (2019). β-Catenin Activation Promotes Immune Escape and Resistance to Anti–PD-1 Therapy in Hepatocellular Carcinoma. Cancer Discovery, 9(8), pp. 1124-1141, DOI: 10.1158/2159-8290.cd-19-0074.
Article145 days agoPalbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma
Julien Bollard, Verónica Miguela, Marina Ruiz de Galarreta, Anu Venkatesh, C. Billie Bian, Mark P. Roberto, Victoria Tovar, Daniela Sia, Pedro Molina-Sánchez, Christie B. Nguyen, Shigeki Nakagawa, Josep M. Llovet, Yujin Hoshida, Amaia Lujambio (2016). Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma. Gut, 66(7), pp. 1286-1296, DOI: 10.1136/gutjnl-2016-312268.
Article145 days agoFigure S3 from β-Catenin Activation Promotes Immune Escape and Resistance to Anti–PD-1 Therapy in Hepatocellular Carcinoma
Marina Ruiz de Galarreta, Erin Bresnahan, Pedro Molina-Sánchez, Katherine E. Lindblad, Bárbara Maier, Daniela Sia, Marc Puigvehí, Verónica Miguela, María Casanova-Acebes, Maxime Dhainaut, Carlos Villacorta-Martín, Aatur D. Singhi, Akshata Moghe, Johann von Felden, Lauren Tal Grinspan, Shuang Wang, Alice O. Kamphorst, Satdarshan P. Monga, Brian D. Brown, Augusto Villanueva, Josep M. Llovet, Miriam Mérad, Amaia Lujambio (2023). Figure S3 from β-Catenin Activation Promotes Immune Escape and Resistance to Anti–PD-1 Therapy in Hepatocellular Carcinoma. , DOI: 10.1158/2159-8290.22536004.
Preprint145 days agoFigure S5 from β-Catenin Activation Promotes Immune Escape and Resistance to Anti–PD-1 Therapy in Hepatocellular Carcinoma
Marina Ruiz de Galarreta, Erin Bresnahan, Pedro Molina-Sánchez, Katherine E. Lindblad, Bárbara Maier, Daniela Sia, Marc Puigvehí, Verónica Miguela, María Casanova-Acebes, Maxime Dhainaut, Carlos Villacorta-Martín, Aatur D. Singhi, Akshata Moghe, Johann von Felden, Lauren Tal Grinspan, Shuang Wang, Alice O. Kamphorst, Satdarshan P. Monga, Brian D. Brown, Augusto Villanueva, Josep M. Llovet, Miriam Mérad, Amaia Lujambio (2023). Figure S5 from β-Catenin Activation Promotes Immune Escape and Resistance to Anti–PD-1 Therapy in Hepatocellular Carcinoma. , DOI: 10.1158/2159-8290.22535998.
Preprint145 days agoSupplementary Data from β-Catenin Activation Promotes Immune Escape and Resistance to Anti–PD-1 Therapy in Hepatocellular Carcinoma
Marina Ruiz de Galarreta, Erin Bresnahan, Pedro Molina-Sánchez, Katherine E. Lindblad, Bárbara Maier, Daniela Sia, Marc Puigvehí, Verónica Miguela, María Casanova-Acebes, Maxime Dhainaut, Carlos Villacorta-Martín, Aatur D. Singhi, Akshata Moghe, Johann von Felden, Lauren Tal Grinspan, Shuang Wang, Alice O. Kamphorst, Satdarshan P. Monga, Brian D. Brown, Augusto Villanueva, Josep M. Llovet, Miriam Mérad, Amaia Lujambio (2023). Supplementary Data from β-Catenin Activation Promotes Immune Escape and Resistance to Anti–PD-1 Therapy in Hepatocellular Carcinoma. , DOI: 10.1158/2159-8290.22535989.
Preprint145 days ago